GLP-1 drugs , or glucagon-like peptide-1 compounds, represent a remarkable innovation in how we approach diabetes mellitus . These new therapies function to imitating the body’s natural GLP-1 hormone , which promotes glucose regulation and diminishes glucose release. Beyond glucose regulation, studies show that GLP-1 medications may also deliver